Ventilator-associated pneumonia occurred less frequently in patients who received inhaled amikacin vs. placebo. Fewer infection-related ventilator-associated complications took place with amikacin.

Amikacin sulfate 100mg/2mL, 500mg/2mL, 1g/4mL; soln for IM inj or IV infusion after dilution; contains sulfites. Give by IM inj; or IV infusion over 30–60 mins. 15mg/kg per day in 2–3 divided ...

Teva Pharmaceuticals is voluntarily recalling seven lots of amikacin sulfate injection USP, 500 mg/2 mL (250 mg/mL) and 1 g/4 mL (250 mg/mL) vials because of potential presence of glass ...

Bayer AG (BAYN.XE) said on Friday that Amikacin Inhale, an integrated drug-device combination being tested in patients with a type of pneumonia, failed to meet the primary objective in a phase 3 ...

Credit: Getty Images. ALIS has previously been designated orphan drug status, breakthrough therapy status and a Qualified Infectious Disease Product. Insmed announced the submission of its New ...

abscessus management. Study: In vitro synergy between manuka honey and amikacin against Mycobacterium abscessus complex shows potential for nebulisation therapy. Image Credit: HikoPhotography ...